Sugi Predict

Sugi Predict / Compounds / SCHEMBL488491

SCHEMBL488491

SCHEMBL488491

CN1CCC(NC(=O)c2ccc(-c3cnc(N)c(OCc4c(F)ccc(F)c4Cl)c3)s2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 8/20 0.48
▸ JAK2 O60674 1/20 0.42
▸ MAP4K3 Q8IVH8 1/20 0.42
▸ PIK3CA P42336 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ AXL P30530 1/20 0.39
▸ MERTK Q12866 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ BMPR1B O00238 3/20 0.38
▸ BMPR1A P36894 3/20 0.38
▸ ACVRL1 P37023 3/20 0.38
▸ ACVR1 Q04771 3/20 0.38
▸ TGFBR1 P36897 2/20 0.38
▸ WNT1 P04628 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ MAPK13 O15264 1/20 0.37
▸ MAPK12 P53778 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452915 1.00 MET (0.48) METJAK2MAP4K3PIK3CAMTOR
SCHEMBL487528 0.86 MET (0.60) METJAK2MAP4K3AXLMERTK
SCHEMBL30452905 0.86 MET (0.60) METJAK2MAP4K3AXLMERTK
SCHEMBL487709 0.85 MET (0.49) METJAK2MAP4K3ALDH1A1
SCHEMBL30454688 0.85 MET (0.49) METJAK2MAP4K3ALDH1A1
SCHEMBL30452521 0.84 MET (0.53) METJAK2MAP4K3
SCHEMBL487713 0.84 MET (0.53) METJAK2MAP4K3
SCHEMBL487873 0.84 AXL (0.57) METJAK2MAP4K3AXLMERTK
SCHEMBL30453612 0.84 AXL (0.57) METJAK2MAP4K3AXLMERTK
SCHEMBL488069 0.81 ALDH1A1 (0.52) METJAK2MAP4K3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4695588-B2 — — 2011-06-08 — — JP claimed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-7230098-B2 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer SUGEN, INC. (US) 2007-06-12 — — US disclosed
US-7230098-B2 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer SUGEN, INC. (US) 2007-06-12 — — US disclosed
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors SUGEN, INC. 2007-03-29 — — US disclosed
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors SUGEN, INC. 2007-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors MET, MAP4K1, MAP4K2 MET 1/4885JAK2 287/4885MAP4K3 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.